Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results
These findings provide evidence for shared decision-making between patients and physicians to consider extending the rescreening intervals after an NCS result beyond the currently recommended 10 years, particularly for individuals with a low-risk profile. These results showed, as a proof of concepts, the importance of considering known CRC risk factors when making decisions for colonoscopy rescreening.
Authors
- Georgios Polychronidis (ORCID: https://orcid.org/0000-0002-9819-8179)
- Mingyang Song (ORCID: https://orcid.org/0000-0002-1324-0316)
- Anette Hjartåker (ORCID: https://orcid.org/0000-0003-3002-4030)
- Paula Berstad (ORCID: https://orcid.org/0000-0002-9025-4455)
- Markus Dines Knudsen (ORCID: https://orcid.org/0000-0001-9306-8327)
- Shuji Ogino (ORCID: https://orcid.org/0000-0002-3909-2323)
- Kai Wang (ORCID: https://orcid.org/0000-0002-5614-5618)
- Liang Wang (ORCID: https://orcid.org/0000-0002-5247-6727)
- Zhe Fang (ORCID: https://orcid.org/0000-0003-0864-3644)
- Andrew T. Chan (ORCID: https://orcid.org/0000-0001-7284-6767)
Institutions
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Sun Yat-sen University (CN)
- University of Oslo (NO)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Massachusetts General Hospital (US)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Cancer Registry of Norway (NO)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1001/jamaoncol.2024.5227
- Citations
- 13
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 3.67